Skip to content

Opening book details…

Can I read Low-molecular weight forms of cyclin E differentiate ovarian carcinoma from cells of mesothelial origin and are associated with poor survival in ovarian carcinoma on EtoBox?

Low-molecular weight forms of cyclin E differentiate ovarian carcinoma from cells of mesothelial origin and are associated with poor survival in ovarian carcinoma by Ben Davidson; Martina Skrede; Ilvars Silins; Ie-Ming Shih; Claes G. Trope; Vivi Ann Flørenes is a Medicine article available to read on EtoBox.

What is Low-molecular weight forms of cyclin E differentiate ovarian carcinoma from cells of mesothelial origin and are associated with poor survival in ovarian carcinoma about?

## Abstract ## BACKGROUND. The authors recently reported on the role of cyclin E in differentiating ovarian/primary peritoneal carcinoma from malignant peritoneal mesothelioma using gene expression arrays. In the current study, they analyzed the expression of low‐molecular weight (LMW) forms of cyclin E in ovarian carcinoma, malignant mesothelioma, and benign reactive effusions. ## METHODS. Cyclin E protein expression was analyzed in 98 effusions (72 ovarian carcinomas, 14 malignant mesotheliomas, and 12 reactive specimens) using immunoblotting. Sixty‐two ovarian carcinoma effusions were studied further for cyclin E expression using immunohistochemistry. The correlations between cyclin E expression in ovarian carcinoma and clinical parameters, including chemotherapy response, were analyzed. ## RESULTS. LMW forms of cyclin E were identified in 54 of 72 ovarian carcinoma effusions (75%) compared with 1 of 14 malignant mesothelioma effusions (7%) and 1 of 12 reactive effusions (8%) (__P__ < .001). Their presence in ovarian carcinoma was associated with a higher percentage of cyclin E‐positive cells (__P__ = .001) and increased staining intensity (__P__ < .001) using immunohistochemist

Who reads Low-molecular weight forms of cyclin E differentiate ovarian carcinoma from cells of mesothelial origin and are associated with poor survival in ovarian carcinoma?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Ben Davidson; Martina Skrede; Ilvars Silins; Ie-Ming Shih; Claes G. Trope; Vivi Ann Flørenes
Publisher
John Wiley and Sons; Wiley (John Wiley & Sons); John Wiley & Sons Inc.; Wiley (ISSN 0008-543X)
Published
2007
Language
EN
Field
Medicine (Health Sciences)

More by Ben Davidson; Martina Skrede; Ilvars Silins; Ie-Ming Shih; Claes G. Trope; Vivi Ann Flørenes

Browse all works by Ben Davidson; Martina Skrede; Ilvars Silins; Ie-Ming Shih; Claes G. Trope; Vivi Ann Flørenes